| Direct oral anticoagulants toxicity in children: an overview and practical guide | | |
| Development and validation of capillary zone electrophoresis and high-performance liquid chromatography methods for the determination of oral anticoagulant Edoxaban in pharmaceutical tablets. | Electrophoresis | 2022 |
| Monitoring of Direct Oral Anticoagulants Plasma Levels for Secondary Stroke Prevention. | Journal of Thrombosis and Haemostasis | 2022 |
| Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians | Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne | 2020 |
| Antithrombotika und Antihämorrhagika | | 2020 |
| Oral anticoagulants: Optimizing venous thromboembolism management | Journal of Applied Hematology | 2019 |
| Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation with warfarin or edoxaban: An in-depth analysis from the ENGAGE AF-TIMI 48 randomized trial | Journal of Clinical Neuroscience | 2021 |
| Efficacy and Safety of Clinically Driven Low-Dose Treatment with Direct Oral Anticoagulants in Asians with Atrial Fibrillation: a Systematic Review and Meta-analysis | Cardiovascular Drugs and Therapy | 2021 |
| Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation and (Morbid) Obesity or Low Body Weight: a Systematic Review and Meta-Analysis | Cardiovascular Drugs and Therapy | 2021 |
| Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review | Advances in Therapy | 2020 |
| Simple LC-MS/MS method using core-shell ODS microparticles for the simultaneous quantitation of edoxaban and its major metabolites in human plasma | Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences | 2020 |
| Comparing stroke prevention therapy of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: a nationwide retrospective observational study | BMC Medicine | 2020 |
| Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes | Journal of Thrombosis and Thrombolysis | 2020 |
| Cardiovascular Risk Management and Hepatitis C: Combining Drugs | Clinical Pharmacokinetics | 2019 |
| Recurrent venous thromboembolism in primary membranous nephropathy despite direct Xa inhibitor therapy | Journal of Nephrology | 2019 |
| Consensus in cardiology on non-vitamin-K oral anticoagulants for patients with atrial fibrillation | Current Medical Research and Opinion | 2019 |
| Appropriateness of dabigatran dosing in patients with nonvalvular atrial fibrillation (NVAF): A retrospective study conducted in a tertiary care university hospital in the eastern province of Saudi Arabia | Journal of the Saudi Heart Association | 2019 |
| Emergency Reversal of Anticoagulation | Western Journal of Emergency Medicine | 2019 |
| Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease | Clinical Journal of the American Society of Nephrology: CJASN | 2019 |
| Edoxaban in Asian Patients With Atrial Fibrillation: Effectiveness and Safety | Journal of the American College of Cardiology | 2018 |
| Oral Anticoagulation in Patients With Liver Disease | Journal of the American College of Cardiology | 2018 |
| Anticoagulation Reversal | Emergency Medicine Clinics of North America | 2018 |
| Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study | BJOG: an International Journal of Obstetrics and Gynaecology | 2018 |
| Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation | Stroke | 2018 |
| Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation | Seminars in Nephrology | 2018 |
| Augmented Renal Clearance in Critically Ill Patients: A Systematic Review | Clinical Pharmacokinetics | 2018 |
| Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health system | Journal of Thrombosis and Thrombolysis | 2018 |
| Review: An overview and analysis of novel oral anticoagulants and their dental implications | Gerodontology | 2018 |
| Pulmonary embolism four days after interruption of therapy with rivaroxaban | Hamostaseologie | 2017 |
| Monitoring and Reversal of Oral Anticoagulation in Hospitalized Patients | Hospital Medicine Clinics | 2017 |
| Anticoagulation in Pulmonary Embolism: Update in the Age of Direct Oral Anticoagulants | Techniques in Vascular and Interventional Radiology | 2017 |
| Reversal of apixaban anticoagulation by four-factor prothrombin complex concentrates in healthy subjects: a randomized three-period crossover study | Journal of Thrombosis and Haemostasis | 2017 |
| Anti-thrombotic therapy for atrial fibrillation in patients with chronic kidney disease: Current views | Hemodialysis International | 2017 |
| Indications and appropriate selection of novel oral anticoagulants in patients with atrial fibrillation | Heart | 2017 |
| Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance | American Journal of Medicine | 2017 |
| Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide | Advances in Therapy | 2017 |
| [Vitamin K antagonists : Is their prescription really "medical malpractice" today?] | Der Internist | 2017 |
| 2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force | Journal of the American College of Cardiology | 2017 |
| Pharmacokinetics and Pharmacodynamics of the Nonvitamin K Antagonist Oral Anticoagulant Edoxaban When Administered Alone or After Switching from Rivaroxaban or Dabigatran Etexilate in Healthy Subjects | Clinical Drug Investigation | 2016 |
| Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial | Circulation | 2016 |
| Creatinine Clearance Is Not Equal to Glomerular Filtration Rate and Cockcroft-Gault Equation Is Not Equal to CKD-EPI Collaboration Equation | American Journal of Medicine | 2016 |
| Direct Oral Anticoagulants in Cirrhosis | Current Treatment Options in Gastroenterology | 2016 |
| Edoxaban: Impact on routine and specific coagulation assays. A practical laboratory guide | Thrombosis and Haemostasis | 2016 |
| Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice | Drugs | 2015 |
| Considerations for Systemic Anticoagulation in ESRD | Seminars in Dialysis | 2015 |
| Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives | European Journal of Haematology | 2015 |
